Recursion Pharmaceuticals
RXRX
#4202
Rank
$1.98 B
Marketcap
$4.94
Share price
-6.59%
Change (1 day)
-43.66%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - P/B ratio

P/B ratio as of April 2025 : 2.06

According to Recursion Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 36.3584.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Recursion Pharmaceuticals - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-312.79-39.25%
2023-12-314.5952.67%
2022-12-313.01-43.58%
2021-12-315.33
2020-12-31N/A